CHE

Chemed Corporation (CHE)

Last Price$550.6(0.9%)
Market Cap$8,290.2M
LTM Net Debt to Free Cash Flow
(0.3x)
5Y avg
0.4x
Medical - Care Facilities industry median
1.6x
Stock quality & Intrinsic value
7/10
(0.3%) overvalued

Chemed Corporation Net Debt to Free Cash Flow

Annual
Quarterly
LTM
Industry median
Company stand-alone
CHE
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Net Debt to Free Cash Flow
2.9x
3.3x
1.6x
3.0x
2.4x
0.1x
1.3x
0.7x
1.1x
0.8x
1.3x
0.2x
0.4x
0.3x
0.4x
0.8x
(0.1x)
1.2x
0.7x
(0.4x)
CHE
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CHE and see if it's the right time to invest.
Dive in

Chemed Corporation (CHE) Net Debt to Free Cash Flow comparison analysis

Crunching data... Almost there!

CHE key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Chemed Corporation's Net Debt to Free Cash Flow?

As of today, Microsoft Corp's last 12-month Net Debt to Free Cash Flow is (0.3x), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Net Debt to Free Cash Flow for Chemed Corporation have been 0.3x over the past three years, and 0.4x over the past five years.

2) Is Chemed Corporation's Net Debt to Free Cash Flow Good?

As of today, Chemed Corporation's Net Debt to Free Cash Flow is (0.3x), which is lower than industry median of 1.6x. It indicates that Chemed Corporation's Net Debt to Free Cash Flow is Good.

3) How does Chemed Corporation's Net Debt to Free Cash Flow compare to its peers?

As of today, Chemed Corporation's Net Debt to Free Cash Flow is (0.3x), which is lower than peer median of 3.1x. The list of peers includes DVA, ENSG, UHS, FMS, THC, OPCH, AMED, EHC, HCA, ACHC.